Men’s Health Update

High Gleason Pattern at PSM Ups Prostate Cancer Relapse Risk

Publish Date March 22, 2019

Gleason pattern 4 or 5 found at a positive surgical margin following robot-assisted radical prostatectomy predicts early biochemical recurrence.

Prostate Cancer Mortality Lowest With Radical Prostatectomy

Publish Date March 21, 2019

In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.

TRT Speeds Potency Recovery After Prostate Surgery

Publish Date March 19, 2019

In a study, all men who received testosterone replacement therapy within 1 year of robot-assisted radical prostatectomy had full potency recovery at 24 months.

TRT Reduces Post-RARP Recurrence Risk in Low-Risk Prostate Cancer

Publish Date March 18, 2019

Testosterone replacement therapy prolonged time to disease progression among men who underwent radical surgery for localized prostate cancer.

BPH Prostatic Artery Embolization Facilitated With MR Angiography

Publish Date March 12, 2019

Improved visualization of prostatic arteries shortens procedure time and decreases radiation exposure, new findings suggest.

Intense ADT Prior to RP May Improve Outcomes in Locally Advanced PCa

Publish Date March 8, 2019

A phase 2 study demonstrated higher rates of pathologic complete response or minimal residual disease.

Long-Term Use of Low-Dose Aspirin May Lower PCa Mortality

Publish Date March 7, 2019

A population-based study found no effect of low-dose aspirin use within 1 year of diagnosis on prostate cancer death risk.

ED, Atherosclerosis Link Documented By Penile Artery Imaging

Publish Date March 5, 2019

Investigators using a bone-seeking radiopharmaceutical show for the first time that atherosclerosis in penile arteries is associated with an increased risk of erectile dysfunction.

Time from Definitive Therapy to ADT Predicts mCRPC Risk

Publish Date March 1, 2019

Time from definitive therapy for localized prostate cancer to the start of androgen deprivation therapy (ADT) independently predicts the risk of metastatic castration-resistant prostate cancer (mCRPC) and death, a new study suggests. The study, led by Neeraj Agarwal, MD, of the Huntsman Cancer Institute at the University of Utah in Salt Lake City, included 253…

Prostate Cancer Risk After Single Negative Biopsy Quantified

Publish Date March 1, 2019

Almost one quarter of men who have a single negative prostate biopsy are eventually diagnosed with prostate cancer (PCa) within 20 years, according to investigators. The finding is from a study of 95,675 men who had a negative first transrectal ultrasound (TRUS)-guided prostate biopsy from January 1994 to October 2014. The 5-, 10-, 15, and…